XML 54 R41.htm IDEA: XBRL DOCUMENT v3.21.1
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (FY) (Tables)
12 Months Ended
Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS [Abstract]  
Effect of Restatement on Financial Statements
The following summarizes the effect of the Restatement on each financial statement line item for each period presented herein and as of the date of the Company’s consummation of its IPO.

  
As
Previously
Reported
  
Adjustments
  
As
Restated
 
Balance sheet as of September 17, 2020 (audited)
         
Warrant Liability
 
$
  
$
16,290,000
  
$
16,290,000
 
Total Liabilities
  
8,579,943
   
16,290,000
   
24,869,943
 
Class A Common Stock Subject to Possible Redemption
  
218,646,370
   
(16,290,000
)
  
202,384,370
 
Class A common stock
  
113
   
163
   
276
 
Additional Paid-in Capital
  
5,001,136
   
579,837
   
5,580,973
 
Accumulated Deficit
  
(1,818
)
  
(580,000
)
  
(581,818
)
Total Stockholders’ Equity
  
5,000,006
   
   
5,000,006
 
             
Balance sheet as of September 30, 2020 (unaudited)
            
Warrant Liability
 
$
  
$
16,109,000
  
$
16,109,000
 
Total Liabilities
  
8,101,692
   
16,109,000
   
24,210,692
 
Class A Common Stock Subject to Possible Redemption
  
218,646,030
   
(16,109,000
)
  
202,537,030
 
Class A common stock
  
114
   
161
   
275
 
Additional Paid-in Capital
  
5,029,475
   
398,839
   
5,428,314
 
Accumulated deficit
  
(30,155
)
  
(399,000
)
  
(429,155
)
Total Stockholders’ Equity
  
5,000,009
   
   
5,000,009
 
             
Balance sheet as of December 31, 2020 (audited)
            
Warrant Liability
 
$
  
$
23,530,000
  
$
23,530,000
 
Total Liabilities
  
8,365,328

  
23,530,000
   
31,895,328
 
Class A Common Stock Subject to Possible Redemption
  
218,249,000

  
(23,530,000
)
  
194,719,000
 
Class A Common Stock
  
118

  
235
   
353
 
Additional Paid-in Capital
  
5,426,501

  
7,819,765
   
13,246,266
 
Accumulated Deficit
  
(427,187
)  
(7,820,000
)
  
(8,247,187
)
Total Stockholders’ Equity
  
5,000,007

  
   
5,000,007
 
             
Statement of operations for the three months ended September 30, 2020 (unaudited)
            
Change in fair value of warrant liability
  
   
181,000
   
181,000
 
Transaction costs allocated to warrant liability
  
   
(580,000
)
  
(580,000
)
Loss before provision for income taxes
  
(30,155
)
  
(399,000
)
  
(429,155
)
Net loss
  
(30,155
)  
(399,000
)
  
(429,155
)
Basic and diluted net loss per share:
            
Class B common stock
  
(0.01
)
  
(0.06
)
  
(0.07
)
             
Statement of operations for the Period from June 23, 2020 (inception) to September 30, 2020 (unaudited)
            
Change in fair value of warrant liability
  
   
181,000
   
181,000
 
Transaction costs allocated to warrant liability
  
   
(580,000
)
  
(580,000
)
Loss before provision for income taxes
  
(30,155
)  
(399,000
)
  
(429,155
)
Net loss
  
(30,155
)  
(399,000
)
  
(429,155
)
Basic and diluted net loss per share:
            
Class B common stock
  
(0.01
)  
(0.06
)
  
(0.07
)
             
Statement of operations for the Period from June 23, 2020 (inception) to December 31, 2020 (audited)
            
Change in fair value of warrant liability
  
   
(7,240,000
)
  
(7,240,000
)
Transaction costs allocated to warrant liability
  
   
(580,000
)
  
(580,000
)
             
Net loss
  
(427,187
)  
(7,820,000
)
  
(8,247,187
)
Basic and diluted net loss per share:
            
Class B common stock
  
(0.08
)  
(1.43
)  
(1.51
)
             
Cash flow statement for the period from June 23, 2020 (inception) to September 30, 2020 (unaudited)
            
Net loss
  
(30,155
)  
(399,000
)
  
(429,155
)
Change in fair value of warrant liability
  
   
(181,000
)
  
(181,000
)
Transaction costs allocated to warrant liability
     
580,000
   
580,000
 
Net cash used in operating activities
  
(24,003
)
  
   
(24,003
)

Cash flow statement for the period from June 23, 2020 (inception) to December 31, 2020 (audited)
         
Net loss
  
(427,187
)  
(7,820,000
)
  
(8,247,187
)
Change in fair value of warrant liability
  
   
7,240,000
   
7,240,000
 
Transaction costs allocated to warrant liability
     
580,000
   
580,000
 
Net cash used in operating activities
  
(455,960
)
  
   
(455,960
)